A detailed history of Forsta Ap Fonden transactions in Danaher Corp stock. As of the latest transaction made, Forsta Ap Fonden holds 162,222 shares of DHR stock, worth $39.4 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
162,222
Previous 157,522 2.98%
Holding current value
$39.4 Million
Previous $39.4 Million 14.58%
% of portfolio
0.35%
Previous 0.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$239.25 - $280.76 $1.12 Million - $1.32 Million
4,700 Added 2.98%
162,222 $45.1 Million
Q2 2024

Aug 08, 2024

SELL
$235.51 - $267.98 $3.09 Million - $3.51 Million
-13,100 Reduced 7.68%
157,522 $39.4 Million
Q1 2024

May 07, 2024

SELL
$224.58 - $256.19 $2.92 Million - $3.33 Million
-13,000 Reduced 7.08%
170,622 $42.6 Million
Q4 2023

Feb 06, 2024

SELL
$185.1 - $233.13 $2.42 Million - $3.05 Million
-13,100 Reduced 6.66%
183,622 $42.5 Million
Q3 2023

Oct 25, 2023

BUY
$233.08 - $265.59 $1.07 Million - $1.22 Million
4,600 Added 2.39%
196,722 $48.8 Million
Q2 2023

Aug 03, 2023

BUY
$224.99 - $256.14 $44,998 - $51,228
200 Added 0.1%
192,122 $46.1 Million
Q1 2023

Apr 21, 2023

BUY
$239.75 - $277.0 $2.71 Million - $3.13 Million
11,300 Added 6.26%
191,922 $48.4 Million
Q4 2022

Feb 02, 2023

BUY
$241.42 - $282.29 $6.52 Million - $7.62 Million
27,000 Added 17.58%
180,622 $47.9 Million
Q3 2022

Oct 17, 2022

SELL
$247.06 - $1507.4 $271,766 - $1.66 Million
-1,100 Reduced 0.71%
153,622 $39.7 Million
Q2 2022

Aug 11, 2022

BUY
$237.11 - $299.66 $782,463 - $988,878
3,300 Added 2.18%
154,722 $39.2 Million
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $1.75 Million - $2.15 Million
6,800 Added 4.7%
151,422 $44.4 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $1.34 Million - $1.51 Million
4,600 Added 3.29%
144,622 $47.6 Million
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $762,188 - $930,804
-2,800 Reduced 1.96%
140,022 $42.6 Million
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $5.63 Million - $6.79 Million
25,000 Added 21.22%
142,822 $38.3 Million
Q1 2021

May 11, 2021

BUY
$212.38 - $245.9 $1.68 Million - $1.94 Million
7,900 Added 7.19%
117,822 $26.5 Million
Q4 2020

Feb 09, 2021

BUY
$212.5 - $245.46 $5.91 Million - $6.82 Million
27,800 Added 33.85%
109,922 $24.4 Million
Q3 2020

Oct 22, 2020

SELL
$177.16 - $215.33 $4.59 Million - $5.58 Million
-25,931 Reduced 24.0%
82,122 $17.7 Million
Q2 2020

Aug 11, 2020

BUY
$128.7 - $176.83 $978,119 - $1.34 Million
7,600 Added 7.57%
108,053 $19.1 Million
Q1 2020

May 04, 2020

SELL
$121.39 - $169.05 $20.8 Million - $28.9 Million
-171,100 Reduced 63.01%
100,453 $13.9 Million
Q4 2019

Feb 12, 2020

SELL
$133.47 - $153.48 $8.79 Million - $10.1 Million
-65,869 Reduced 19.52%
271,553 $41.7 Million
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $230,180 - $248,999
-1,700 Reduced 0.5%
337,422 $48.7 Million
Q2 2019

Aug 07, 2019

SELL
$124.88 - $143.73 $524,496 - $603,666
-4,200 Reduced 1.22%
339,122 $48.5 Million
Q1 2019

May 08, 2019

BUY
$97.62 - $132.29 $5.36 Million - $7.26 Million
54,900 Added 19.03%
343,322 $45.3 Million
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $309,590 - $357,538
3,264 Added 1.14%
288,422 $29.7 Million
Q3 2018

Nov 07, 2018

SELL
$98.13 - $108.9 $8.55 Million - $9.49 Million
-87,100 Reduced 23.4%
285,158 $31 Million
Q2 2018

Aug 15, 2018

SELL
$96.1 - $103.24 $3.05 Million - $3.27 Million
-31,700 Reduced 7.85%
372,258 $36.7 Million
Q1 2018

May 09, 2018

SELL
$92.16 - $103.8 $276,480 - $311,400
-3,000 Reduced 0.74%
403,958 $39.6 Million
Q4 2017

Feb 08, 2018

SELL
$85.26 - $94.62 $1.53 Million - $1.7 Million
-18,000 Reduced 4.24%
406,958 $37.8 Million
Q3 2017

Oct 31, 2017

BUY
$79.29 - $88.45 $33.7 Million - $37.6 Million
424,958
424,958 $36.5 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.